SPHK2 and fibrosis: In a SphK2 knockout (SphK2−/−) mouse model, we revealed that CS-induced pulmonary inflammation and fibrosis were significantly decreased, and SphK2 deficiency rescued CFTR activity and preserved pulmonary function by suppressing the S1P secretion.